ACUTE MYELOID LEUKEMIA IN REMISSION
Clinical trials for ACUTE MYELOID LEUKEMIA IN REMISSION explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA IN REMISSION trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA IN REMISSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could less be more? new study tests lower drug dose to keep leukemia at bay
Disease control Recruiting nowThis study looks at whether a lower dose of the drug venetoclax can help people with acute myeloid leukemia (AML) stay in remission while causing fewer serious side effects. About 41 adults whose AML is in remission after initial treatment will take a reduced dose of venetoclax. …
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE2 • Sponsor: Northwell Health • Aim: Disease control
Last updated May 17, 2026 02:07 UTC
-
New drug hopes to keep leukemia away after transplant
Disease control Recruiting nowThis early-phase study tests an experimental drug called ziftomenib in adults with acute myeloid leukemia (AML) who have had a stem cell transplant. The goal is to find a safe dose and see if the drug can help prevent the cancer from coming back. About 22 participants will take t…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New drug combo aims to boost survival in AML stem cell transplants
Disease control Recruiting nowThis study compares two drug combinations given before a stem cell transplant for adults with acute myeloid leukemia (AML) in remission. The goal is to see if using clofarabine plus busulfan leads to better 2-year survival than the standard fludarabine plus busulfan. About 302 pa…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE2 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
Radioactive antibody blasts cancer before stem cell rescue in High-Risk leukemia trial
Disease control Recruiting nowThis study tests a radioactive antibody (211At-BC8-B10) followed by a donor stem cell transplant for people with high-risk leukemia or myelodysplastic syndrome (MDS) that has come back or not responded to treatment. The antibody targets cancer cells and delivers radiation, then c…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE1, PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC